| Factors | No. of patient | 3 years OS% | 5 years OS% | P value (univariate) | P value (multivariate) |
| Age (years) <60 ≥60 |
32 59 |
84.8 66.7 |
84.8 60.1 | 0.020 |
|
| Pretreatment Hemoglobin <12 mg/dl ≥12 mg/dl |
31 17 |
62.5 100 |
41.7 100 | 0.009 |
|
| Pathology Papillary Serous Clear Cell Undifferentiated Carcinosarcoma |
30 12 8 41 |
85.7 71.1 85.7 73.4 |
85.7 71.1 85.7 58.7 | 0.341 |
|
| Lymph node status Nx N0 N + ve |
66 18 7 |
81.4 72.2 68.6 |
76 54.1 0 | 0.154 |
|
| FIGO stage Early (I,II) Advanced (III,IV) |
68 23 |
84.9 34.9 |
75.1 0 | 0.004 | 0.041 |
| Adjuvant EBRT No Yes |
10 81 |
75.0 79.3 |
75.0 74.6 | 0.910 |
|
| Brachytherapy Yes No |
49 42 |
77.7 78.7 |
72.5 59.0 | 0.838 |
|
| Chemotherapy Yes No |
9 80 |
85.7 77.0 |
85.7 66.9 | 0.467 |
|
| Duration from surgery to ERBT ≤8 weeks >8 weeks |
48 32 |
92.9 60.6 |
82.5 48.5 | 0.011 | 0.011 |
| Overall Treatment Period (OAP) ≤8 weeks > 8 weeks |
42 49 |
76.4 80.2 |
50.9 74.8 | 0.250 |
|